![Susan M. Aloyan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Susan M. Aloyan
Hoofd Techniek/Wetenschap/O&O bij Access Closure, Inc.
Profiel
Susan M.
Aloyan is currently the EVP-Regulatory, Clinical & Quality Affairs at Access Closure, Inc. She previously worked as the Director-Regulatory Affairs at Gynecare, Inc. from 2009 to 2013.
Prior to that, she was the Associate Director-Regulatory Affairs at CardioGenesis Corp.
in 1996.
Susan also held the position of Principal at Syntex Corp.
and Vice President-Regulatory Affairs at Conceptus, Inc. She completed her undergraduate degree at Golden Gate University and her graduate degree at the University of Phoenix.
Actieve functies van Susan M. Aloyan
Bedrijven | Functie | Begin |
---|---|---|
Access Closure, Inc.
![]() Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van Susan M. Aloyan
Bedrijven | Functie | Einde |
---|---|---|
CardioGenesis Corp.
![]() CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Corporate Officer/Principal | 01-01-1996 |
Gynecare, Inc. (New Jersey)
![]() Gynecare, Inc. (New Jersey) Medical SpecialtiesHealth Technology Gynecare, Inc. designs medical devices for the treatment of uterine problems. The company was founded on March 8, 1994 and is headquartered in Somerville, NJ. | Algemeen Adviseur | - |
Syntex Corp. | Corporate Officer/Principal | - |
Conceptus, Inc.
![]() Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Algemeen Adviseur | - |
Opleiding van Susan M. Aloyan
Golden Gate University | Undergraduate Degree |
University of Phoenix | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 5 |
---|---|
Access Closure, Inc.
![]() Access Closure, Inc. Medical SpecialtiesHealth Technology Access Closure, Inc. manufactures and distributes medical devices for cardiovascular and peripheral vascular markets. Its products include Mynx ace, Mynx grip, Mynx sealant technology and flash ostial system. The company was in founded in 2002 by Farhad Khosravi and is headquartered in Santa Clara, CA. | Health Technology |
Conceptus, Inc.
![]() Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Health Technology |
Gynecare, Inc. (New Jersey)
![]() Gynecare, Inc. (New Jersey) Medical SpecialtiesHealth Technology Gynecare, Inc. designs medical devices for the treatment of uterine problems. The company was founded on March 8, 1994 and is headquartered in Somerville, NJ. | Health Technology |
Syntex Corp. | Health Technology |
CardioGenesis Corp.
![]() CardioGenesis Corp. Medical SpecialtiesHealth Technology Cardiogenesis Corp. designs, develops, and distributes surgical products for the treatment of refractory angina in patients with chronic cardiac ischemia caused by coronary artery disease. The company was founded by Randy J. Kesten in April 1989 and is headquartered in Irvine, CA. | Health Technology |